Clinical Trial Update: Dasatinib in Combination With Revlimid (and Dexamethasone) [Phase 1]

View source ↗

Summary

Results from a Phase 1 study of dasatinib in combination with Revlimid (lenalidomide) and dexamethasone for multiple myeloma were reported, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Revlimid (lenalidomide)
• Sprycel (dasatinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED | Results posted: 2012-07-20